Harvest Portfolios Group Inc. Sells 11,094 Shares of Intuitive Surgical, Inc. $ISRG

Harvest Portfolios Group Inc. cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 108,497 shares of the medical equipment provider’s stock after selling 11,094 shares during the quarter. Harvest Portfolios Group Inc.’s holdings in Intuitive Surgical were worth $61,448,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in ISRG. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. grew its position in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $27,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Finally, Caitlin John LLC acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Piper Sandler decreased their target price on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Raymond James Financial decreased their price target on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Barclays set a $651.00 price target on Intuitive Surgical and gave the stock an “overweight” rating in a research report on Thursday, April 23rd. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Finally, Truist Financial lowered their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Nineteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

Intuitive Surgical Trading Up 0.4%

ISRG stock opened at $441.58 on Wednesday. The stock has a market capitalization of $156.39 billion, a P/E ratio of 53.52, a price-to-earnings-growth ratio of 3.51 and a beta of 1.51. Intuitive Surgical, Inc. has a 12 month low of $417.74 and a 12 month high of $603.88. The firm has a 50-day moving average price of $461.52 and a 200-day moving average price of $512.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.81 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares of the company’s stock, valued at $782,321.13. The trade was a 28.57% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amy L. Ladd sold 119 shares of the business’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the sale, the director directly owned 120 shares in the company, valued at $55,620. The trade was a 49.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 5,647 shares of company stock worth $2,760,359 over the last 90 days. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.